Abstract:333 Background: Inpatient chemotherapy is not routinely recommended for patients with solid tumors as administration is associated with increased length of stay (LOS), higher healthcare costs, and higher morbidity; and chemotherapy administration within 14 days of death is considered poor quality care. However, inpatient chemotherapy may sometimes be indicated for toxicity monitoring or due to barriers that limit prompt delivery of medications with clinically meaningful benefit. To ensure judicious use of inpatient chemotherapy we are undertaking iterative Plan, Do, Study, Act (PDSA) cycles involving education and policy initiatives on a solid tumor oncology service at an urban, academic medical center. Methods: PDSA cycles followed standard methodology. The initial goal was to reduce inappropriate inpatient chemotherapy use, which was expected to correspond with a 25% overall reduction. The initial intervention consisted of two main components: 1) division-wide education about the indications for inpatient chemotherapy, and 2) formation of a committee to review all chemotherapy requests for adult inpatients with solid tumors. The committee consists of clinicians within division leadership, including the division chief and representatives from operations, quality and safety, and ethics. Requests are sent from inpatient teams to the committee, who review each case for factors supporting inpatient treatment such as patient stability/performance status, clinically meaningful benefit, and practical barriers to outpatient administration. To evaluate the impact of the intervention, data were extracted from the electronic medical record for all patients admitted to the service for the 8.5 months before (12/1/22-8/15/23) and after (8/16/23-4/30/24) the initiation of the first PDSA cycle. Results: At baseline, prior to PDSA cycle 1, there were 930 admissions (n=606 patients), and 111 (11.9%, n=82 patients) received inpatient chemotherapy. During PDSA cycle 1 there were 889 admissions (n=557 patients), and 57 (6.4%, n=35 patients) received inpatient chemotherapy (p 0.9), and 13.1% vs. 11.5% within 30 days of death (p>0.9). Overall, mean LOS for all admissions decreased from 11.1 days to 8.8 days (p<0.001). Conclusions: Preliminary results of this quality improvement initiative using iterative PDSA cycles to optimize inpatient chemotherapy use suggest a benefit. After the first PDSA cycle, there was a 46.3% decrease in the proportion of admissions receiving inpatient chemotherapy, and an overall decrease in LOS. Future PDSA cycles are aimed at limiting end-of-life chemotherapy and streamlining the transition from inpatient to outpatient chemotherapy to reduce delays and improve the patient experience.

S981 Reducing Use of Inpatient FOBT at an Academic Tertiary Medical Center: A Quality Improvement Project

S986 Quality Initiative to Instate Accurate Guaiac Fecal Occult Blood Test Requests and Interpretation to Decrease Unnecessary Testing, Misdiagnosing, and Improve Cost in a Large Community Hospital

Do You Bleed? A 1-Year FOBT Case-Series Study

S406 Assessing the Use of Fecal Occult Blood Tests in a Community Hospital: Phase Two

Reducing unnecessary outpatient group and screen testing at a regional cancer center

Third Annual Fecal Occult Blood Testing in Community Health Clinics

Improving Fecal Immunochemical Test Collection for Colorectal Cancer Screening During the COVID-19 Pandemic

Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms

Environmental impact of a blood test reduction intervention in adult intensive care units: A before and after quality improvement project

Comparison of Efficacy Between Immunochemical Fecal Occult Blood Test and Guaiac-Based Fecal Occult Blood Test for Colorectal Neoplasms Screening

S658 Overutilization of Proton Pump Inhibitors in a Community-Based Hospital: A QI Initiative

219 Incidence and Phenotype at Diagnosis of Inflammatory Bowel Disease Across 9 Countries in Asia-Pacific

A Multimodal Intervention to Reduce C. difficile Infections and Stool Testing

Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening

Improving provider practice patterns in ordering FDG PET/CT for breast cancer patients at a safety-net hospital.

Assessment of the severity of visible blood in the stool using a cluster of neonatal cases -a quality improvement study

Collateral Benefit of Systematic Improvement in Bariatric Surgery Outcomes Following a Single Quality Improvement Project for Bleeding

Quality improvement project to reduce inpatient chemotherapy usage on a solid tumor oncology service.

Quality improvement project aiming to reduce inappropriate use of abdominal x-rays in the ED

"Your Finger or Mine?"-Patient Preferences in the Collection of Fecal Occult Blood Testing in the Emergency Department

Impact of an education and multilevel social comparison–based intervention bundle on use of routine blood tests in hospitalised patients at an academic tertiary care hospital: a controlled pre-intervention post-intervention study